Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ewertz

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
ESMO Open|February 15, 2023
Implementation and clinical benefit of DPYD genotyping in a Danish cancer populationN H Paulsen, P Pfeiffer, M Ewertz, et al.
Journal of Cancer Survivorship : Research and Practice|March 22, 2022
Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivorsSynne-Kristin Hoffart Bøhn, K F Vandraas, C E Kiserud, et al.
Lancet (London, England)|March 25, 2014
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials, P McGale, C Taylor, et al.
Breast Cancer Research and Treatment|April 21, 2022
Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide surveyK Vandraas, R S Falk, S K H Bøhn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2018
Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trialJ Herrstedt, Y Summers, K Jordan, et al.
Lancet (London, England)|October 25, 2011
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials, S Darby, P McGale, et al.
British Journal of Cancer|July 31, 2008
Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopramT L Lash, L Pedersen, D Cronin-Fenton, et al.
British Journal of Cancer|November 20, 2002
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the diseaseN Hamajima, K Hirose, K Tajima, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
ESMO Open|February 15, 2023
Implementation and clinical benefit of DPYD genotyping in a Danish cancer populationN H Paulsen, P Pfeiffer, M Ewertz, et al.
Journal of Cancer Survivorship : Research and Practice|March 22, 2022
Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivorsSynne-Kristin Hoffart Bøhn, K F Vandraas, C E Kiserud, et al.
Lancet (London, England)|March 25, 2014
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials, P McGale, C Taylor, et al.
Breast Cancer Research and Treatment|April 21, 2022
Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide surveyK Vandraas, R S Falk, S K H Bøhn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 30, 2018
Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trialJ Herrstedt, Y Summers, K Jordan, et al.
Lancet (London, England)|October 25, 2011
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials, S Darby, P McGale, et al.
British Journal of Cancer|July 31, 2008
Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopramT L Lash, L Pedersen, D Cronin-Fenton, et al.
British Journal of Cancer|November 20, 2002
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the diseaseN Hamajima, K Hirose, K Tajima, et al.
Pageof 7